6 Apr 2023
New Review Reveals the Critical Role of Progranulin in Cancer
Originally published in Newswise A recent review paper published in the...
3 Apr 2023
XVII Conference of Italian Researchers in the World, 1st April 2023
The team of Sbarro Health Research Organization (SHRO) participated in the XVII...
30 Mar 2023
Top US and Italian Researchers Unite for Cutting-Edge Conference on Medicine, Science, and Technology Hosted by SHRO
Originally published in Newswise The Sbarro Health Research Organization (SHRO), led by Prof. Antonio...
13 Mar 2023
Italia-Usa, AmCham and Consul with successful companies
Originally published in Il Mattino AmCham meets successful companies with ties...
7 Mar 2023
SHRO’s Giordano to Speak at Virtual Workshop on Artificial Intelligence in Medicine
Originally published in Newswise Newswise — March 7, 2023, Philadelphia –...
22 Feb 2023
Cancer: In Italy every year over 8000 patients candidates for liquid biopsy
Rome, 21 February 2023 – Almost 8,000 lung cancer patients...
24 Jan 2023
Malfunctioning Mitochondria at the Heart of Many Cardiovascular Diseases
NewswiseMany cardiovascular diseases, such as atherosclerosis, or ‘hardening of the...
22 Dec 2022
Are the Benefits of New Cancer Drugs Worth the Cost?
Newswise — An international research group including scientists from Italy, the...
29 Nov 2022
Links Between Neurological Involvement and Respiratory Damage in SARS-CoV-2 Infection
Newswise — Researchers working with Sbarro Health Research Organization (SHRO) have...
31 Oct 2022
Dr. Giordano meets Speaker Nancy Pelosi, De Laurentiis & Petrone at the 47th anniversary of NIAF
Professor Antonio Giordano founder of Sbarro Health Research Organization (SHRO) meet...
28 Oct 2022
Cellular Cilium an Early Sign of Mesothelioma Differentiation
As Published on Newswise — A new study investigated the expression...
12 Oct 2022
Adverse Events Linked to PD-1 Blockade in Some Lung Cancer Patients
Original Newswise post Newswise — Treatments with PD-1/PD-L1 immuno-checkpoint inhibitors...